Immediate Impact
16 from Science/Nature 64 standout
Citing Papers
Energy metabolism in health and diseases
2025 Standout
Lactate: A key regulator of the immune response
2025 Standout
Works of Mitchell Revill being referenced
Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mitchell Revill | 243 | 114 | 113 | 6 | 347 | |
| Zvezdan Pavlovic | 281 | 81 | 45 | 5 | 358 | |
| Olivier Masson | 147 | 83 | 111 | 9 | 320 | |
| Milton Cornwall-Brady | 224 | 127 | 70 | 7 | 372 | |
| Chandrika Jeyamohan | 221 | 88 | 143 | 9 | 349 | |
| Mesquita Rodrigues | 246 | 112 | 189 | 7 | 371 | |
| Kristina Diepold | 260 | 66 | 218 | 6 | 394 | |
| T. Okuyama | 274 | 68 | 143 | 8 | 395 | |
| Laura Ghisolfi | 217 | 162 | 114 | 10 | 351 | |
| Susanne van Schelven | 260 | 128 | 182 | 8 | 399 | |
| Xin Chen | 179 | 84 | 71 | 8 | 348 |
All Works
Loading papers...